Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Accelerometer output and its association with energy expenditure in persons with multiple sclerosis.
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigms.
Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
Successful treatment of fingolimod-associated macular edema with intravitreal triamcinolone with continued fingolimod use.
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury.
Immune responses in rapidly progressive dementia: a comparative study of neuroinflammatory markers in Creutzfeldt-Jakob disease, Alzheimer¿s disease and multiple sclerosis.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Tysabri (natalizumab)
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
Origins and significance of astrogliosis in the multiple sclerosis model, MOG peptide EAE.
Fingolimod treatment in multiple sclerosis leads to increased macular volume.
Antinuclear antibodies in pediatric acquired demyelinating diseases of the central nervous system.
Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids.
The invisible gorilla strikes again: sustained inattentional blindness in expert observers.
Alemtuzumab: The advantages and challenges of a novel therapy in MS.
Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
[Transorbital echography for assessment of optical nerve atrophy in demyelinating diseases: a pilot study].
Atypical forms of optic neuritis.
Lipopolysaccharide Upregulates the Expression of CINC-3 and LIX in Primary NG2 Cells.

Pages